Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatitis B | 6 | 2022 | 707 | 1.670 |
Why?
|
Hepatitis B virus | 7 | 2022 | 530 | 1.610 |
Why?
|
Mucormycosis | 4 | 2023 | 102 | 1.590 |
Why?
|
Aspergillosis | 2 | 2023 | 242 | 1.320 |
Why?
|
Virus Activation | 7 | 2022 | 322 | 1.110 |
Why?
|
Cytomegalovirus Infections | 7 | 2023 | 838 | 1.020 |
Why?
|
Agammaglobulinemia | 2 | 2023 | 174 | 0.970 |
Why?
|
Antibodies, Bispecific | 2 | 2024 | 204 | 0.950 |
Why?
|
Mycoses | 5 | 2013 | 386 | 0.850 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2022 | 5708 | 0.850 |
Why?
|
Antiviral Agents | 10 | 2022 | 3062 | 0.820 |
Why?
|
Respiratory Tract Infections | 2 | 2023 | 1013 | 0.740 |
Why?
|
Triazoles | 4 | 2019 | 905 | 0.700 |
Why?
|
Opportunistic Infections | 3 | 2015 | 376 | 0.690 |
Why?
|
Antifungal Agents | 9 | 2023 | 761 | 0.670 |
Why?
|
Hematologic Neoplasms | 6 | 2023 | 1905 | 0.660 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2012 | 614 | 0.550 |
Why?
|
Leukemia | 3 | 2010 | 1527 | 0.520 |
Why?
|
Immunocompromised Host | 9 | 2023 | 865 | 0.490 |
Why?
|
Transplantation | 2 | 2013 | 221 | 0.460 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1031 | 0.450 |
Why?
|
Hepatitis C | 2 | 2020 | 1594 | 0.410 |
Why?
|
Neutropenia | 3 | 2023 | 892 | 0.400 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6087 | 0.400 |
Why?
|
Antibiotic Prophylaxis | 2 | 2008 | 640 | 0.400 |
Why?
|
Multiple Myeloma | 4 | 2024 | 5193 | 0.400 |
Why?
|
Cytomegalovirus | 5 | 2021 | 755 | 0.400 |
Why?
|
Mycology | 1 | 2011 | 13 | 0.380 |
Why?
|
Mucorales | 1 | 2011 | 35 | 0.370 |
Why?
|
Pyrazoles | 2 | 2018 | 2024 | 0.360 |
Why?
|
Pyrimidines | 2 | 2018 | 3050 | 0.320 |
Why?
|
Viruses | 1 | 2012 | 373 | 0.310 |
Why?
|
Skin Diseases, Infectious | 1 | 2008 | 76 | 0.300 |
Why?
|
Soft Tissue Infections | 1 | 2008 | 168 | 0.270 |
Why?
|
Virus Diseases | 1 | 2012 | 722 | 0.260 |
Why?
|
Pneumonia, Pneumocystis | 2 | 2018 | 242 | 0.250 |
Why?
|
Clinical Laboratory Techniques | 1 | 2011 | 749 | 0.250 |
Why?
|
B-Cell Maturation Antigen | 2 | 2023 | 149 | 0.250 |
Why?
|
Cord Blood Stem Cell Transplantation | 3 | 2018 | 305 | 0.250 |
Why?
|
Hepatitis B Surface Antigens | 3 | 2022 | 294 | 0.250 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2007 | 238 | 0.240 |
Why?
|
Bacterial Infections | 1 | 2013 | 1397 | 0.240 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2007 | 342 | 0.230 |
Why?
|
Hepatitis B Antibodies | 2 | 2022 | 155 | 0.220 |
Why?
|
Lung Transplantation | 1 | 2012 | 1310 | 0.210 |
Why?
|
Echinocandins | 1 | 2023 | 53 | 0.210 |
Why?
|
Physicians | 1 | 2021 | 4615 | 0.210 |
Why?
|
Drainage | 1 | 2008 | 1180 | 0.210 |
Why?
|
Neoplasms | 4 | 2022 | 22389 | 0.200 |
Why?
|
Anti-Infective Agents | 2 | 2012 | 986 | 0.200 |
Why?
|
Polyomavirus Infections | 2 | 2014 | 193 | 0.200 |
Why?
|
Nitriles | 2 | 2019 | 984 | 0.190 |
Why?
|
Tumor Virus Infections | 2 | 2014 | 438 | 0.190 |
Why?
|
Hepacivirus | 2 | 2019 | 1342 | 0.180 |
Why?
|
Humans | 54 | 2024 | 768369 | 0.180 |
Why?
|
Fungi | 1 | 2023 | 346 | 0.170 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3210 | 0.170 |
Why?
|
Staphylococcal Infections | 1 | 2008 | 1412 | 0.160 |
Why?
|
Transplantation Conditioning | 2 | 2018 | 1598 | 0.160 |
Why?
|
Pneumocystis carinii | 2 | 2018 | 72 | 0.160 |
Why?
|
DNA, Viral | 3 | 2022 | 2203 | 0.160 |
Why?
|
Tacrolimus | 1 | 2022 | 750 | 0.160 |
Why?
|
Postoperative Complications | 3 | 2020 | 15879 | 0.150 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1727 | 0.150 |
Why?
|
Antineoplastic Agents | 5 | 2020 | 13709 | 0.140 |
Why?
|
Adult | 25 | 2023 | 223528 | 0.140 |
Why?
|
BK Virus | 2 | 2014 | 120 | 0.140 |
Why?
|
Adenine | 3 | 2018 | 993 | 0.140 |
Why?
|
Latent Tuberculosis | 1 | 2019 | 224 | 0.130 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1505 | 0.130 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2018 | 1077 | 0.130 |
Why?
|
Hepatitis B, Chronic | 1 | 2020 | 413 | 0.130 |
Why?
|
Middle Aged | 25 | 2023 | 223406 | 0.130 |
Why?
|
Chemoprevention | 1 | 2017 | 326 | 0.120 |
Why?
|
Transplantation, Homologous | 6 | 2018 | 4834 | 0.120 |
Why?
|
Pyridines | 2 | 2019 | 2888 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2022 | 1376 | 0.120 |
Why?
|
Aged, 80 and over | 8 | 2019 | 59679 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2023 | 81835 | 0.120 |
Why?
|
Rhizomucor | 1 | 2014 | 3 | 0.120 |
Why?
|
Aged | 18 | 2023 | 171514 | 0.110 |
Why?
|
Male | 26 | 2023 | 364761 | 0.110 |
Why?
|
Fetal Blood | 2 | 2018 | 1353 | 0.110 |
Why?
|
Acute Disease | 3 | 2010 | 7245 | 0.110 |
Why?
|
Methotrexate | 1 | 2020 | 1722 | 0.110 |
Why?
|
Immunosuppressive Agents | 3 | 2020 | 4213 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2126 | 0.100 |
Why?
|
Piperidines | 2 | 2018 | 1664 | 0.100 |
Why?
|
Tissue Transplantation | 1 | 2012 | 128 | 0.100 |
Why?
|
Virology | 1 | 2012 | 76 | 0.100 |
Why?
|
Mannans | 1 | 2011 | 58 | 0.100 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2011 | 56 | 0.090 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2005 | 0.090 |
Why?
|
Amphotericin B | 1 | 2011 | 143 | 0.090 |
Why?
|
beta-Glucans | 1 | 2011 | 129 | 0.090 |
Why?
|
HIV | 1 | 2018 | 1587 | 0.090 |
Why?
|
Lymphadenitis | 1 | 2011 | 99 | 0.090 |
Why?
|
Clostridium Infections | 1 | 2017 | 559 | 0.090 |
Why?
|
Female | 22 | 2023 | 396926 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1175 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5426 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1374 | 0.090 |
Why?
|
DNA, Ribosomal | 1 | 2011 | 301 | 0.090 |
Why?
|
DNA, Fungal | 1 | 2011 | 276 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3433 | 0.080 |
Why?
|
Young Adult | 8 | 2019 | 60038 | 0.080 |
Why?
|
Candidiasis | 1 | 2011 | 367 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2019 | 1931 | 0.080 |
Why?
|
Candida albicans | 1 | 2011 | 376 | 0.080 |
Why?
|
Cross Infection | 1 | 2017 | 1425 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2008 | 198 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2702 | 0.070 |
Why?
|
DNA Primers | 1 | 2011 | 2825 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39429 | 0.070 |
Why?
|
HIV Reverse Transcriptase | 1 | 2007 | 212 | 0.070 |
Why?
|
Face | 1 | 2012 | 1031 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14725 | 0.070 |
Why?
|
Cohort Studies | 4 | 2019 | 41782 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11844 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2019 | 65408 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1542 | 0.060 |
Why?
|
Graft Rejection | 2 | 2020 | 4505 | 0.060 |
Why?
|
Community-Acquired Infections | 1 | 2008 | 473 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1282 | 0.060 |
Why?
|
Incidence | 4 | 2022 | 21552 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13589 | 0.060 |
Why?
|
Risk Factors | 7 | 2022 | 74915 | 0.060 |
Why?
|
Graft vs Host Disease | 3 | 2014 | 3042 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5508 | 0.050 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 420 | 0.050 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1544 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 10358 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2017 | 3623 | 0.050 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2007 | 590 | 0.050 |
Why?
|
Patient Selection | 2 | 2021 | 4266 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 330 | 0.050 |
Why?
|
Time Factors | 3 | 2012 | 40271 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12561 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2008 | 1061 | 0.040 |
Why?
|
Hepatitis B Core Antigens | 1 | 2020 | 90 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8751 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1796 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2022 | 423 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4774 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4570 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2020 | 12450 | 0.040 |
Why?
|
Acetates | 1 | 2021 | 318 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2022 | 437 | 0.040 |
Why?
|
Stem Cell Transplantation | 2 | 2020 | 1602 | 0.040 |
Why?
|
Tuberculin Test | 1 | 2019 | 205 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1834 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2518 | 0.040 |
Why?
|
Rubella | 1 | 2018 | 55 | 0.040 |
Why?
|
Herpes Zoster Vaccine | 1 | 2018 | 49 | 0.040 |
Why?
|
Mumps | 1 | 2018 | 71 | 0.040 |
Why?
|
HIV Infections | 2 | 2018 | 17492 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8559 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6347 | 0.030 |
Why?
|
Societies, Medical | 2 | 2020 | 3954 | 0.030 |
Why?
|
Measles | 1 | 2018 | 181 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1668 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2079 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7449 | 0.030 |
Why?
|
Quinazolines | 1 | 2021 | 1376 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15638 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1479 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1439 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3207 | 0.030 |
Why?
|
Anthracyclines | 1 | 2015 | 286 | 0.030 |
Why?
|
Myeloablative Agonists | 1 | 2014 | 210 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 605 | 0.030 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 687 | 0.030 |
Why?
|
Drug Dosage Calculations | 1 | 2012 | 117 | 0.020 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 350 | 0.020 |
Why?
|
Prospective Studies | 3 | 2024 | 54913 | 0.020 |
Why?
|
Fluconazole | 1 | 2011 | 156 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 2019 | 1390 | 0.020 |
Why?
|
Adolescent | 3 | 2017 | 89163 | 0.020 |
Why?
|
Galactose | 1 | 2011 | 299 | 0.020 |
Why?
|
Serum | 1 | 2011 | 208 | 0.020 |
Why?
|
Diarrhea | 1 | 2017 | 1320 | 0.020 |
Why?
|
HIV-1 | 1 | 2007 | 6909 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4040 | 0.020 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 275 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2526 | 0.020 |
Why?
|
Proteoglycans | 1 | 2011 | 807 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8905 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3629 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1557 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21157 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2224 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1765 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2007 | 36 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3230 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1400 | 0.020 |
Why?
|
Didanosine | 1 | 2007 | 151 | 0.020 |
Why?
|
Dideoxynucleosides | 1 | 2007 | 135 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3550 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6537 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1891 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5455 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 868 | 0.020 |
Why?
|
Lamivudine | 1 | 2007 | 368 | 0.020 |
Why?
|
Codon | 1 | 2007 | 598 | 0.020 |
Why?
|
Tissue Donors | 1 | 2015 | 2377 | 0.020 |
Why?
|
Viral Load | 1 | 2014 | 3374 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 30031 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2533 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 622 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4861 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2015 | 2896 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12875 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3708 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4877 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2007 | 888 | 0.010 |
Why?
|
Drug Resistance, Viral | 1 | 2007 | 868 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1596 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8510 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6320 | 0.010 |
Why?
|
Graft Survival | 1 | 2012 | 3890 | 0.010 |
Why?
|
HeLa Cells | 1 | 2007 | 3091 | 0.010 |
Why?
|
Pneumonia | 1 | 2012 | 2162 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10601 | 0.010 |
Why?
|
Skin | 1 | 2014 | 4520 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7575 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9379 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15965 | 0.010 |
Why?
|
Lung | 1 | 2014 | 10090 | 0.010 |
Why?
|
United States | 1 | 2015 | 73120 | 0.000 |
Why?
|
Brain | 1 | 2014 | 27439 | 0.000 |
Why?
|